跳至主要内容
临床试验/KCT0008955
KCT0008955已完成Unknown

Comparison of remimazolam and midazolam administration in ketamin infusion therapy for chronic pain patients

Konkuk University Medical Center0 个研究点目标入组 62 人开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
入组人数
62

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20(Year) 至 90(Year)(—)
性别
All

入选标准

  • 1) a target disease
  • Chronic pain diseases subject to sedative treatment using ketamine, such as complex regional pain syndrome, fiber muscle pain, and neuropathic pain.
  • 2) Selection criteria and exclusion criteria of study subjects
  • - Patients who are being treated for chronic pain for more than 6 months
  • - Patients with neuropathic pain or fibromyalgia
  • - Patients who agree with the study process

排除标准

  • - Patients who are hypersensitive or allergic to ketamine, remimazolam, and midazolam
  • - Drugs or alcoholics
  • - Patients with heart disease such as angina, arrhythmia, and heart failure
  • - Pregnant or potentially pregnant patients
  • - Patients who disagree with the study

研究者

相似试验